J. Midgley

发表

Control of a hospital outbreak of methicillin-resistant Staphylococcus aureus infections: value of an isolation unit.

D. Shanson, D. Johnstone, J. Midgley, 1985, The Journal of hospital infection.

Clinically significant azole cross‐resistance in Candida isolates from HIV‐positive patients with oral candidosis

B. Gazzard, J. Midgley, J. Cartledge, 1997, AIDS.

Multiple strains of Candida albicans in the oral cavity of HIV positive and HIV negative patients

R. Anthony, S. Howell, J. Midgley, 1994 .

Non-albicans oral candidosis in HIV-positive patients.

B. Gazzard, J. Midgley, J. Cartledge, 1999, The Journal of antimicrobial chemotherapy.

Use of terbinafine in HIV‐positive subjects: pilot studies in onychomycosis and oral candidiasis

D. Hawkins, M. Youle, E. Evans, 1996, The British journal of dermatology.

Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV.

B. Gazzard, D. Smith, Don E. Smith, 1991, AIDS.

Unresponsive HIV-related oro-oesophageal candidosis--an evaluation of two new in-vitro azole susceptibility tests.

B. Gazzard, M. Petrou, D. Shanson, 1997, The Journal of antimicrobial chemotherapy.

Monoclonal immunofluorescence compared with silver stain for investigating Pneumocystis carinii pneumonia.

D. Shanson, O. Husain, J. Midgley, 1991, Journal of clinical pathology.

Itraconazole cyclodextrin solution--effective treatment for HIV-related candidosis unresponsive to other azole therapy.

B. Gazzard, M. Youle, J. Midgley, 1994, The Journal of antimicrobial chemotherapy.

Treatment of HIV‐related fluconazole‐resistant oral candidosis with D0870, a new triazole antifungal

B. Gazzard, D. Hawkins, D. Denning, 1998, AIDS.

Itraconazole cyclodextrin solution: the role of in vitro susceptibility testing in predicting successful treatment of HIV‐related fluconazole‐resistant and fluconazole‐susceptible oral candidosis

B. Gazzard, J. Midgley, J. Cartledge, 1997, AIDS.

A randomised, double-blind study of itraconazole versus placebo in the treatment and prevention of oral or oesophageal candidosis in patients with HIV infection.

D. Smith, B. Gazzard, J. Midgley, 1999, International journal of clinical practice.

STREPTOBACILLUS MONILIFORMIS ISOLATED FROM BLOOD IN FOUR CASES OF HAVERHILL FEVER First Outbreak in Britain

J. Cheesbrough, R. Finch, B. Gazzard, 1983, The Lancet.

Prior fluconazole exposure as an independent risk factor for fluconazole resistant candidosis in HIV positive patients: a case-control study.

B. Gazzard, J. Midgley, J. Cartledge, 1997, Genitourinary medicine.